Author:
Carr Shamus R.,Friedberg Joseph S.
Reference27 articles.
1. Loveland P, Christie M, Hammerschlag G, Irving L, Steinfort D. Diagnostic yield of pleural fluid cytology in malignant effusions: an Australian tertiary centre experience. Intern Med J. 2018;48(11):1318–24. https://doi.org/10.1111/imj.13991.
2. Ascoli V, Bosco D, Carnovale Scalzo C. Cytologic re-evaluation of negative effusions from patients with malignant mesothelioma. Pathologica. 2011;103(6):318–24.
3. Miller Q, Meschter C, Neumaster T, et al. Comparison of pleurodesis by erythromycin, talc, doxycycline, and diazepam in a rabbit model. J Surg Educ. 2007;64(1):41–5. https://doi.org/10.1016/j.cursur.2006.07.006.
4. Chen J, Li Z, Xu N, Zhang X, Wang Y, Lin D. Efficacy of medical thoracoscopic talc pleurodesis in malignant pleural effusion caused by different types of tumors and different pathological classifications of lung cancer. Int J Clin Exp Med. 2015;8(10):18945–53.
5. Fysh ETH, Tan SK, Read CA, et al. Pleurodesis outcome in malignant pleural mesothelioma. Thorax. 2013;68(6):594–6. https://doi.org/10.1136/thoraxjnl-2012-203043.